Literature DB >> 24170569

What is the best measure of daytime sleepiness in adults with heart failure?

Barbara Riegel1, Alexandra L Hanlon, Xuemei Zhang, Desiree Fleck, Steven L Sayers, Lee R Goldberg, William S Weintraub.   

Abstract

PURPOSE: To identify the best screening measure of daytime sleepiness in adults with heart failure (HF). DATA SOURCES: A total of 280 adults with HF completed the Epworth Sleepiness Scale, the Stanford Sleepiness Scale, and a single Likert item measuring daytime sleepiness. The sensitivity and specificity of these self-report measures were assessed in relation to a measure of daytime dysfunction from poor sleep quality.
CONCLUSIONS: Only 16% of the sample reported significant daytime dysfunction because of poor sleep quality. Those reporting daytime dysfunction were likely to be younger (p < .001), to be unmarried (p = .002), to have New York Heart Association (NYHA) functional class IV HF (p = .015), and to report low income (p = .006) and fewer hours of sleep (p = .015). The measure of daytime sleepiness that was most sensitive to daytime dysfunction was a single Likert item measured on a 10-point (1-10) scale. Patients with a score ≥4 were 2.4 times more likely to have daytime dysfunction than those with a score <4. IMPLICATIONS FOR PRACTICE: Complaints of daytime dysfunction because of poor sleep are not common in adults with HF. Routine use of a single question about daytime sleepiness can help nurse practitioners to identify those HF patients with significant sleep issues that may require further screening. ©2012 The Author(s) Journal compilation ©2012 American Association of Nurse Practitioners.

Entities:  

Keywords:  Heart failure; outcomes; screening; sleep disorders

Mesh:

Year:  2012        PMID: 24170569      PMCID: PMC4130314          DOI: 10.1111/j.1745-7599.2012.00784.x

Source DB:  PubMed          Journal:  J Am Assoc Nurse Pract        ISSN: 2327-6886            Impact factor:   1.165


  45 in total

1.  Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea.

Authors:  Yasuyuki Kaneko; John S Floras; Kengo Usui; Julie Plante; Ruzena Tkacova; Toshihiko Kubo; Shin-ichi Ando; T Douglas Bradley
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 2.  The two-process model of sleep regulation revisited.

Authors:  Peter Achermann
Journal:  Aviat Space Environ Med       Date:  2004-03

3.  Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure.

Authors:  Barbara Riegel; Stephen T Moelter; Sarah J Ratcliffe; Susan J Pressler; Sabina De Geest; Sheryl Potashnik; Desiree Fleck; Daohang Sha; Steven L Sayers; William S Weintraub; Terri E Weaver; Lee R Goldberg
Journal:  J Card Fail       Date:  2010-12-24       Impact factor: 5.712

4.  Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard.

Authors:  M W Johns
Journal:  J Sleep Res       Date:  2000-03       Impact factor: 3.981

5.  Quantification of sleepiness: a new approach.

Authors:  E Hoddes; V Zarcone; H Smythe; R Phillips; W C Dement
Journal:  Psychophysiology       Date:  1973-07       Impact factor: 4.016

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  Daytime sleepiness and its evaluation.

Authors:  Raymond Cluydts; Elke De Valck; Edwin Verstraeten; Paul Theys
Journal:  Sleep Med Rev       Date:  2002-04       Impact factor: 11.609

8.  Study of a patient population investigated for excessive daytime sleepiness (EDS).

Authors:  F Laffont; A Mallet; G Mayer; S Meunier; M Minz; S N'Doye; M A Quilfen-Buzare
Journal:  Neurophysiol Clin       Date:  2002-12       Impact factor: 3.734

Review 9.  Executive control of attention in sleep apnea patients: theoretical concepts and methodological considerations.

Authors:  Edwin Verstraeten; Raymond Cluydts
Journal:  Sleep Med Rev       Date:  2004-08       Impact factor: 11.609

10.  Sensitivity of the stanford sleepiness scale to the effects of cumulative partial sleep deprivation and recovery oversleeping.

Authors:  J Herscovitch; R Broughton
Journal:  Sleep       Date:  1981       Impact factor: 5.849

View more
  6 in total

1.  Daytime sleepiness and risk of coronary heart disease and stroke: results from the Nurses' Health Study II.

Authors:  James E Gangwisch; Kathryn Rexrode; John P Forman; Kenneth Mukamal; Dolores Malaspina; Diane Feskanich
Journal:  Sleep Med       Date:  2014-04-13       Impact factor: 3.492

Review 2.  Mechanisms of reduced sleepiness symptoms in heart failure and obstructive sleep apnea.

Authors:  Victoria M Pak; Lisa Strouss; Henry K Yaggi; Nancy S Redeker; Vahid Mohsenin; Barbara Riegel
Journal:  J Sleep Res       Date:  2018-11-13       Impact factor: 3.981

3.  Double jeopardy: the influence of excessive daytime sleepiness and impaired cognition on health-related quality of life in adults with heart failure.

Authors:  Barbara Riegel; Sarah J Ratcliffe; William S Weintraub; Steven L Sayers; Lee R Goldberg; Sheryl Potashnik; Terri E Weaver; Susan J Pressler
Journal:  Eur J Heart Fail       Date:  2012-04-17       Impact factor: 15.534

4.  What puts heart failure patients at risk for poor medication adherence?

Authors:  George J Knafl; Barbara Riegel
Journal:  Patient Prefer Adherence       Date:  2014-07-17       Impact factor: 2.711

5.  Does reading a book in bed make a difference to sleep in comparison to not reading a book in bed? The People's Trial-an online, pragmatic, randomised trial.

Authors:  Elaine Finucane; Ann O'Brien; Shaun Treweek; John Newell; Kishor Das; Sarah Chapman; Paul Wicks; Sandra Galvin; Patricia Healy; Linda Biesty; Katie Gillies; Anna Noel-Storr; Heidi Gardner; Mary Frances O'Reilly; Declan Devane
Journal:  Trials       Date:  2021-12-04       Impact factor: 2.279

6.  The People's Trial: supporting the public's understanding of randomised trials.

Authors:  Elaine Finucane; Ann O'Brien; Shaun Treweek; John Newell; Kishor Das; Sarah Chapman; Paul Wicks; Sandra Galvin; Patricia Healy; Linda Biesty; Katie Gillies; Anna Noel-Storr; Heidi Gardner; Mary Frances O'Reilly; Declan Devane
Journal:  Trials       Date:  2022-03-09       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.